A method for predicting the development of osteoporosis in women with primary hypothyroidism

摘要

method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 u0440u0430u0437u0432u0438u0442u0438u00a0 osteoporosis in women with primary thyroid problem, including u0432u044bu00a0u0432u043bu0435u043du0438u0435 u0440u0430u0437u0432u0438u0442u0438u00a0 osteoporosis risk factors: age of menopause (up to 45 years), low body weight, and body mass index (bmi), the presence of fractures in the history, the establishment of their u0433u0440u0430u0434u0430u0446u0438u0439, 0 -, 1 -, and numeric values, after which u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 about u0433u043du043eu0441u0442u0438u0447u0435u0441u043au0438u0435 factors f1 and f2 on the formulas, the u043eu0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0 orderfurther u0432u044bu00a0u0432u043bu00a0u044eu0442 risk factors: duration of menstrual period, u0441u043eu0441u0442u043eu00a0u043du0438u0435 u043fu043eu0441u0442u043cu0435u043du043eu043fu0430u0443u0437u044b, u0441u043eu0441u0442u043eu00a0u043du0438u0435 compensation u0433u0438u043fu043eu0442u0438u0440u0435u043eu0437u0430, dose and u0434u043bu0438u0442u0435u043bu044cu043d awn of u0442u0438u0440u0435u043eu0438u0434u043du044bu0445 hormones and forward-looking factors f1 and f2 u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 on formulas;f1 = - 5,51 + 4,98X1 + 0,89u04452 + 3,18u04453 + 3,27u04454 - 1,11X5 + 2,37u04456 + 2,98u04457 + 5,19u04458 + 1,18u04459,;f2 = 0.92, 0,62X1 - 0,24u04452 + 1,27u04453 - 0,94u04454 + 0,74u04455 + 2,54u04456 + 0,14u04457 + 1,04u04458 + 0,31u04459,;accordingly, where x1 is the nine scales and numerical u0437u043du0430u0447u0435u043du0438u00a0 risk factors, and x1 - body weight less than 62 kg h2 - bmi less than 25 kg / m2, the x3 - a history of fractures, 64 menopause 45 years of age, duration of menstrual period x5 in the lives of women less than 30 years, u04456 - u0441u043eu0441u0442u043eu00a0u043du0438u0435 u043fu043eu0441u0442u043cu0435u043du043eu043fu0430u0443u0437u044b, u04457 - u043au043eu043cu043fu0435u043du0441u0430u0446u0438u00a0 u0433u0438u043fu043eu0433u0438u0440u0435u043eu0437u0430,x8 - u0441u0443u0442u043eu0447u043du0430u00a0 dose u043bu0435u0432u043eu0442u0438u0440u043eu043au0441u0438u043du0430 more than 100 micrograms; u04459 - duration of admission u0442u0438u0440u0435u043eu0438u0434u043du044bu0445 hormones for more than 5 years, and in F1F2 predict high risk, and low risk of f2 - f1 u0442u0438u00a0 osteoporosis.